Clara Cosgaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Clara Cosgaya has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ignasi Roca
Department of Microbiology, Hospital Clínic-CDB, University of Barcelona, Barcelona, Spain; Institute of Global Health (ISGlobal), Barcelona, Spain; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III, Madrid, Spain
7 shared publications - Jordi Vila
Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto Salud Carlos III, Madrid, Spain
5 shared publications Marta Marí-Almirall
ISGlobal, Hospital Clínic - University of Barcelona, Barcelona, Spain
4 shared publicationsNoraida Mosqueda
Department of Clinical Microbiology and ISGlobal, Barcelona Ctr. Int, Health Res. CRESIB, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
4 shared publications- Paul G. Higgins
Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
3 shared publications - Ado Van Assche
Laboratory for Process Microbial Ecology and Bioinspirational Management (PME&BIM), Department of Microbial and Molecular Systems (M2S), KU Leuven, Sint-Katelijne-Waver, Belgium
2 shared publications
Latest Publications
- Open Access
- 24 October 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 2429
In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group
The increased use of molecular identification methods and mass spectrometry has revealed that Acinetobacter spp. of the A. baumannii (Ab) group other than A. baumannii are increasingly being recovered from human samples and may pose a health challenge if neglected. In this study 76 isolates of 5 species within the Ab group (A. baumannii n = 16, A. lactucae n = 12, A. nosocomialis n = 16, A. pittii n = 20, and A. seifertii n = 12), were compared in terms of antimicrobial susceptibility, carriage of intrinsic resistance genes, biofilm formation, and the ability to kill Caenorhabditis elegans in an infection assay. In agreement with previous studies, antimicrobial resistance was common among A. baumannii while all other species were generally more susceptible. Carriage of genes encoding different efflux pumps was frequent in all species and the presence of intrinsic class D β-lactamases was reported in A. baumannii, A. lactucae (heterotypic synonym of A. dijkshoorniae) and A. pittii but not in A. nosocomialis and A. seifertii. A. baumannii and A. nosocomialis presented weaker pathogenicity in our in vitro and in vivo models than A. seifertii, A. pittii and, especially, A. lactucae. Isolates from the former species showed decreased biofilm formation and required a longer time to kill C. elegans nematodes. These results suggest relevant differences in terms of antibiotic susceptibility patterns among the members of the Ab group as well as highlight a higher pathogenicity potential for the emerging species of the group in this particular model. Nevertheless, the impact of such potential in the human host still remains to be determined.
- 24 October 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 2429
Open AccessIn vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group
The increased use of molecular identification methods and mass spectrometry has revealed that Acinetobacter spp. of the A. baumannii (Ab) group other than A. baumannii are increasingly being recovered from human samples and may pose a health challenge if neglected. In this study 76 isolates of 5 species within the Ab group (A. baumannii n = 16, A. lactucae n = 12, A. nosocomialis n = 16, A. pittii n = 20, and A. seifertii n = 12), were compared in terms of antimicrobial susceptibility, carriage of intrinsic resistance genes, biofilm formation, and the ability to kill Caenorhabditis elegans in an infection assay. In agreement with previous studies, antimicrobial resistance was common among A. baumannii while all other species were generally more susceptible. Carriage of genes encoding different efflux pumps was frequent in all species and the presence of intrinsic class D β-lactamases was reported in A. baumannii, A. lactucae (heterotypic synonym of A. dijkshoorniae) and A. pittii but not in A. nosocomialis and A. seifertii. A. baumannii and A. nosocomialis presented weaker pathogenicity in our in vitro and in vivo models than A. seifertii, A. pittii and, especially, A. lactucae. Isolates from the former species showed decreased biofilm formation and required a longer time to kill C. elegans nematodes. These results suggest relevant differences in terms of antibiotic susceptibility patterns among the members of the Ab group as well as highlight a higher pathogenicity potential for the emerging species of the group in this particular model. Nevertheless, the impact of such potential in the human host still remains to be determined.
- 1 September 2019
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 305, 108248
Pathogenic Acinetobacter species including the novel Acinetobacter dijkshoorniae recovered from market meat in Peru
- 1 September 2019
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 305, 108248
Pathogenic Acinetobacter species including the novel Acinetobacter dijkshoorniae recovered from market meat in Peru
- 1 March 2017
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 23 (3) , 210.e1-210.e9
MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species
- 1 March 2017
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 23 (3) , 210.e1-210.e9
MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species
- Open Access
- 12 January 2017
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 5 (2) , e01480-16
Draft Genome Sequence of JVAP01 T , the Type Strain of the Novel Species Acinetobacter dijkshoorniae
Here, we report the draft genome sequence of the type strain of Acinetobacter dijkshoorniae , a novel human pathogen within the Acinetobacter calcoaceticus – Acinetobacter baumannii (ACB) complex. Strain JVAP01 T has an estimated genome size of 3.9 Mb, exhibits a 38.8% G+C content, and carries a plasmid with the bla NDM-1 carbapenemase gene.
- 12 January 2017
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 5 (2) , e01480-16
Open AccessDraft Genome Sequence of JVAP01 T , the Type Strain of the Novel Species Acinetobacter dijkshoorniae
Here, we report the draft genome sequence of the type strain of Acinetobacter dijkshoorniae , a novel human pathogen within the Acinetobacter calcoaceticus – Acinetobacter baumannii (ACB) complex. Strain JVAP01 T has an estimated genome size of 3.9 Mb, exhibits a 38.8% G+C content, and carries a plasmid with the bla NDM-1 carbapenemase gene.
- Open Access
- 1 October 2016
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 66 (10) , 4105-4111
Acinetobacter dijkshoorniae sp. nov., a member of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex mainly recovered from clinical samples in different countries
The recent advances in bacterial species identification methods have led to the rapid taxonomic diversification of the genus Acinetobacter . In the present study, phenotypic and molecular methods have been used to determine the taxonomic position of a group of 12 genotypically distinct strains belonging to the Acinetobacter calcoaceticus –Acinetobacter baumannii (ACB) complex, initially described by Gerner-Smidt and Tjernberg in 1993, that are closely related to Acinetobacter pittii . Strains characterized in this study originated mostly from human samples obtained in different countries over a period of 15 years. rpoB gene sequences and multilocus sequence typing were used for comparisons against 94 strains representing all species included in the ACB complex. Cluster analysis based on such sequences showed that all 12 strains grouped together in a distinct clade closest to Acinetobacter pittiithat was supported by bootstrap values of 99 %. Values of average nucleotide identity based on blast between the genome sequence of strain JVAP01T (NCBI accession no. LJPG00000000) and those of other species from the ACB complex were always <91.2 %, supporting the species status of the group. In addition, the metabolic characteristics of the group matched those of the ACB complex and the analysis of their protein signatures by matrix-assisted laser desorption ionization time-of-flight MS identified some specific peaks. Our results support the designation of these strains as representing a novel species, for which the name Acinetobacter dijkshoorniae sp. nov. is proposed. The type strain is JVAP01T (=CECT 9134T=LMG 29605T).
- 1 October 2016
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 66 (10) , 4105-4111
Open AccessAcinetobacter dijkshoorniae sp. nov., a member of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex mainly recovered from clinical samples in different countries
The recent advances in bacterial species identification methods have led to the rapid taxonomic diversification of the genus Acinetobacter . In the present study, phenotypic and molecular methods have been used to determine the taxonomic position of a group of 12 genotypically distinct strains belonging to the Acinetobacter calcoaceticus –Acinetobacter baumannii (ACB) complex, initially described by Gerner-Smidt and Tjernberg in 1993, that are closely related to Acinetobacter pittii . Strains characterized in this study originated mostly from human samples obtained in different countries over a period of 15 years. rpoB gene sequences and multilocus sequence typing were used for comparisons against 94 strains representing all species included in the ACB complex. Cluster analysis based on such sequences showed that all 12 strains grouped together in a distinct clade closest to Acinetobacter pittiithat was supported by bootstrap values of 99 %. Values of average nucleotide identity based on blast between the genome sequence of strain JVAP01T (NCBI accession no. LJPG00000000) and those of other species from the ACB complex were always <91.2 %, supporting the species status of the group. In addition, the metabolic characteristics of the group matched those of the ACB complex and the analysis of their protein signatures by matrix-assisted laser desorption ionization time-of-flight MS identified some specific peaks. Our results support the designation of these strains as representing a novel species, for which the name Acinetobacter dijkshoorniae sp. nov. is proposed. The type strain is JVAP01T (=CECT 9134T=LMG 29605T).
- 1 September 2015
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 46 (3) , 355-356
Rapid detection of β-lactamases directly from positive blood cultures using a loop-mediated isothermal amplification (LAMP)-based assay
- 1 September 2015
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 46 (3) , 355-356
Rapid detection of β-lactamases directly from positive blood cultures using a loop-mediated isothermal amplification (LAMP)-based assay
- Open Access
- 1 October 2013
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (10) , 5155-5157
Globally Expanding Carbapenemase Finally Appears in Spain: Nosocomial Outbreak of Acinetobacter baumannii Producing Plasmid-Encoded OXA-23 in Barcelona, Spain
Resistance of Acinetobacter baumannii clinical isolates to carbapenems is on the rise worldwide mainly in association with the production of OXA-23. Until recently, however, OXA-23 was absent in Spain. In this work, we report the molecular characterization of a hospital outbreak of OXA-23-producing A. baumannii in Barcelona caused by a multidrug-resistant (MDR) clone belonging to international clone IC-II/sequence type ST85 between October 2010 and May 2011. bla OXA-23 was carried in a plasmid of 90 kb and located within the composite transposon Tn 2006 .
- 1 October 2013
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (10) , 5155-5157
Open AccessGlobally Expanding Carbapenemase Finally Appears in Spain: Nosocomial Outbreak of Acinetobacter baumannii Producing Plasmid-Encoded OXA-23 in Barcelona, Spain
Resistance of Acinetobacter baumannii clinical isolates to carbapenems is on the rise worldwide mainly in association with the production of OXA-23. Until recently, however, OXA-23 was absent in Spain. In this work, we report the molecular characterization of a hospital outbreak of OXA-23-producing A. baumannii in Barcelona caused by a multidrug-resistant (MDR) clone belonging to international clone IC-II/sequence type ST85 between October 2010 and May 2011. bla OXA-23 was carried in a plasmid of 90 kb and located within the composite transposon Tn 2006 .